Original ArticleSimple and sensitive determination of Sparfloxacin (cas 111542-93-9) in pharmaceuticals and biological samples by immunoassay
-
Add time:09/08/2019 Source:sciencedirect.com
Plasma quinolone concentrations are not routinely measured in clinical practice. However, in order to optimize quinolone treatment, monitoring of plasma concentrations could sometimes be useful particularly in critically ill patients. In this study, anti-Sparfloxacin (cas 111542-93-9) antibody was obtained by immunizing rabbits with sparfloxacin conjugated with bovine serum albumin using isobutyl chloroformate method. After the assay procedure was optimized, the standard curve of sparfloxacin was established. The practical measuring range of the competitive ELISA extended from 5 ng/mL to 2 μg/mL. The recovery rates and coefficients of variation for rat plasma, urine and tissues were 87.7–106.2% and 4.8–15.3%, respectively. To demonstrate the potential of the ELISA, a preliminary pharmacokinetics and tissue distribution study of sparfloxacin in rats and quantitative analysis of sparfloxacin in several pharmaceuticals were performed and compared with high-performance liquid chromatography (HPLC). The experimental data indicated that the proposed method would be a valuable tool in therapeutic drug monitoring (TDM) for sparfloxacin.
We also recommend Trading Suppliers and Manufacturers of Sparfloxacin (cas 111542-93-9). Pls Click Website Link as below: cas 111542-93-9 suppliers
Prev:Cobalt(II) complexes of Sparfloxacin (cas 111542-93-9): Characterization, structure, antimicrobial activity and interaction with DNA and albumins
Next:Cellular, transcriptomic and methylome effects of individual and combined exposure to BPA, BPF, BPS on mouse spermatocyte GC-2 cell line) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Cobalt(II) complexes of Sparfloxacin (cas 111542-93-9): Characterization, structure, antimicrobial activity and interaction with DNA and albumins09/07/2019
- Determination of Sparfloxacin (cas 111542-93-9) with CdSe/CdS quantum dots as fluorescent probes09/06/2019
- Short communicationImpact of Sparfloxacin (cas 111542-93-9) on melanogenesis and antioxidant defense system in normal human melanocytes HEMa-LP – An in vitro study09/05/2019
- A novel Fe3O4/graphene oxide/citrus peel-derived bio-char based nanocomposite with enhanced adsorption affinity and sensitivity of ciprofloxacin and Sparfloxacin (cas 111542-93-9)09/04/2019
- Phosphine derivatives of Sparfloxacin (cas 111542-93-9) – Synthesis, structures and in vitro activity09/03/2019
- Combined experimental and theoretical studies on the diorganotin(IV) complexes of Sparfloxacin (cas 111542-93-9): Synthesis, spectroscopic and DFT studies, and biological activity09/02/2019
- Sparfloxacin (cas 111542-93-9)09/01/2019